Wednesday, 26 August 2026European Markets

AZERION Stock Falls By 31% In The Last 21 Sessions

Loading stream...

(VIANEWS) - Shares of AZERION (AEX-Index: AZRN.AS) fell by a staggering 31.67% in 21 sessions from €2.81 to €1.92 at 16:10 EST on Thursday, following the last session's downward trend. AEX-Index is dropping 0.08% to €741.17, after three sequential sessions in a row of gains.

AZERION's last close was €1.87, 79.73% under its 52-week high of €9.20.

About AZERION

Azerion Group N.V. operates a digital entertainment and media platform worldwide. Its integrated platform provides technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company was founded in 2014 and is headquartered in Schiphol-Rijk, the Netherlands. Azerion Group N.V. is a subsidiary of Principion Holding B.V.

Earnings Per Share

As for profitability, AZERION has a trailing twelve months EPS of €-167.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -313.99%.

Moving Average

AZERION's value is way under its 50-day moving average of €3.23 and way below its 200-day moving average of €5.95.

Yearly Top and Bottom Value

AZERION's stock is valued at €1.92 at 16:10 EST, way below its 52-week high of €9.20 and way higher than its 52-week low of €1.64.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 452.6M for the twelve trailing months.

More news about AZERION (AZRN.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com